Annual Accounts Payable
$3.28 M
+$1.25 M+61.44%
31 December 2023
Summary:
Profound Medical annual accounts payable is currently $3.28 million, with the most recent change of +$1.25 million (+61.44%) on 31 December 2023. During the last 3 years, it has fallen by -$100.00 thousand (-2.96%). PROF annual accounts payable is now -18.78% below its all-time high of $4.04 million, reached on 31 December 2017.PROF Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.40 M
+$725.00 K+27.14%
01 September 2024
Summary:
Profound Medical quarterly accounts payable is currently $3.40 million, with the most recent change of +$725.00 thousand (+27.14%) on 01 September 2024. Over the past year, it has increased by +$1.38 million (+68.45%). PROF quarterly accounts payable is now -15.96% below its all-time high of $4.04 million, reached on 31 December 2017.PROF Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PROF Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.4% | +68.5% |
| 3 y3 years | -3.0% | +56.8% |
| 5 y5 years | +14.3% | +64.3% |
PROF Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -3.0% | +61.4% | at high | +68.5% |
| 5 y | 5 years | -3.0% | +61.4% | at high | +89.3% |
| alltime | all time | -18.8% | >+9999.0% | -16.0% | >+9999.0% |
Profound Medical Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.40 M(+27.1%) |
| June 2024 | - | $2.67 M(-7.1%) |
| Mar 2024 | - | $2.88 M(-12.4%) |
| Dec 2023 | $3.28 M(+61.4%) | $3.28 M(+62.8%) |
| Sept 2023 | - | $2.02 M(-16.8%) |
| June 2023 | - | $2.42 M(+17.9%) |
| Mar 2023 | - | $2.06 M(+1.1%) |
| Dec 2022 | $2.03 M(-36.1%) | $2.03 M(-36.1%) |
| Dec 2021 | $3.18 M(-6.0%) | $3.18 M(+46.8%) |
| Sept 2021 | - | $2.17 M(-6.1%) |
| June 2021 | - | $2.31 M(-7.6%) |
| Mar 2021 | - | $2.50 M(-26.1%) |
| Dec 2020 | $3.38 M | $3.38 M(+88.5%) |
| Sept 2020 | - | $1.79 M(-10.7%) |
| June 2020 | - | $2.01 M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $2.01 M(-33.7%) |
| Dec 2019 | $3.03 M(+5.4%) | $3.03 M(+46.5%) |
| Sept 2019 | - | $2.07 M(+16.0%) |
| June 2019 | - | $1.78 M(-33.6%) |
| Mar 2019 | - | $2.68 M(-6.6%) |
| Dec 2018 | $2.87 M(-28.9%) | $2.87 M(+34.2%) |
| Sept 2018 | - | $2.14 M(+1.9%) |
| June 2018 | - | $2.10 M(-7.5%) |
| Mar 2018 | - | $2.27 M(-43.8%) |
| Dec 2017 | $4.04 M(+206.6%) | $4.04 M(+6.4%) |
| Sept 2017 | - | $3.80 M(+188.2%) |
| Dec 2016 | $1.32 M(>+9900.0%) | $1.32 M(>+9900.0%) |
| Mar 2015 | - | $2600.00(-51.9%) |
| Dec 2014 | $9200.00 | - |
| Sept 2014 | - | $5400.00 |
FAQ
- What is Profound Medical annual accounts payable?
- What is the all time high annual accounts payable for Profound Medical?
- What is Profound Medical annual accounts payable year-on-year change?
- What is Profound Medical quarterly accounts payable?
- What is the all time high quarterly accounts payable for Profound Medical?
- What is Profound Medical quarterly accounts payable year-on-year change?
What is Profound Medical annual accounts payable?
The current annual accounts payable of PROF is $3.28 M
What is the all time high annual accounts payable for Profound Medical?
Profound Medical all-time high annual accounts payable is $4.04 M
What is Profound Medical annual accounts payable year-on-year change?
Over the past year, PROF annual accounts payable has changed by +$1.25 M (+61.44%)
What is Profound Medical quarterly accounts payable?
The current quarterly accounts payable of PROF is $3.40 M
What is the all time high quarterly accounts payable for Profound Medical?
Profound Medical all-time high quarterly accounts payable is $4.04 M
What is Profound Medical quarterly accounts payable year-on-year change?
Over the past year, PROF quarterly accounts payable has changed by +$1.38 M (+68.45%)